Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Distinct correlations between clinical and laboratory-based instrumented balance measures in individuals with multiple sclerosis: a cross-sectional study.
Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway.
Tumefactive Multiple Sclerosis Mimicking a High-Grade Glioma: A Case Report and Literature Review.
Skimmianine Pretreatment Attenuates Cerebellar Neuroinflammation and Myelin Injury Following Experimental Cerebral Ischemia-Reperfusion.
Disability and race in MS: Does socioeconomic disadvantage play a role?
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.
Early injury-induced responses in the transected adult human sural nerve.
Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis.
Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine.
Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal Study.
Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective.
Diagnostic overshadowing in primary progressive multiple sclerosis with coexisting tethered cord syndrome and long-standing urological dysfunction: a case report and literature review.
Sodium Butyrate Attenuates Sevoflurane-Induced Impaired Myelination and Neurobehavioral Deficits in Neonatal Mice via the H3K9ac/BDNF/TrkB Pathway.
Multitarget therapeutic potential of sulforaphane in ethidium bromide-induced neurotoxicity in multiple sclerosis-like pathology: comparison with omaveloxolone and dimethyl fumarate on neuroprotection and systemic recovery.
The Impact of Sleep-Related Disorders on the Sleep Quality in Patients With Multiple Sclerosis in a Saudi Cohort.
Feasibility of a registry-integrated eHealth program for managing fatigue and cognitive problems in multiple sclerosis.
Evidence of musculoskeletal pain sensitization in patients with multiple sclerosis: Case-control study.
Monocular pendular nystagmus following optic neuritis in multiple sclerosis: a case report and pathophysiological review.
Multiple sclerosis as an asynchronous neuroinflammatory system.
Differential Characteristics, Mechanisms, and Clinical Strategies for Perioperative Dry Eye in Presenile Cataract and Age-Related Cataract.
Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies-3rd Edition.
Urea vs. tolvaptan for hospitalized patients with SIADH.
A case-control study of the oral microbiome among Australian female adults with relapsing-remitting multiple sclerosis: A pilot study.
Sequential associations of myelin dysfunction with Aβ and Tau pathology in Alzheimer's disease: a dynamic myelin perturbation.
The risk of neuropathy associated with biological therapy in juvenile idiopathic arthritis children.
Pages
« first
‹ previous
…
1049
1050
1051
1052
1053
1054
1055
1056
1057
…
next ›
last »